Related Experiment Video
Updated: Jan 21, 2026

An Emerging Target Paradigm to Evoke Fast Visuomotor Responses on Human Upper Limb Muscles
Published on: August 25, 2020
The Mitochondrion as an Emerging Therapeutic Target in Cancer
Katherine G Roth1, Isa Mambetsariev1, Prakash Kulkarni1
1Department of Medical Oncology and Therapeutics Research, City of Hope, Duarte, CA, USA.
Abstract:
Mitochondria have emerged as important pharmacological targets because of their key role in cellular proliferation and death. In tumor tissues, mitochondria can switch metabolic phenotypes to meet the challenges of high energy demand and macromolecular synthesis. Furthermore, mitochondria can engage in crosstalk with the tumor microenvironment, and signals from cancer-associated fibroblasts can impinge on mitochondria. Cancer cells can also acquire a hybrid phenotype in which both glycolysis and oxidative phosphorylation (OXPHOS) can be utilized. This hybrid phenotype can facilitate metabolic plasticity of cancer cells more specifically in metastasis and therapy-resistance. In light of the metabolic heterogeneity and plasticity of cancer cells that had until recently remained unappreciated, strategies targeting cancer metabolic dependency appear to be promising in the development of novel and effective cancer therapeutics.
Insights
Mitochondria are key targets in cancer therapy. Targeting cancer
Area of Science:
- Mitochondrial biology
- Cancer metabolism
- Tumor microenvironment
Background:
- Mitochondria play crucial roles in cellular proliferation and death.
- Tumor cells exhibit metabolic plasticity, utilizing glycolysis and oxidative phosphorylation (OXPHOS).
- Mitochondria interact with the tumor microenvironment, influenced by factors like cancer-associated fibroblasts.
Purpose of the Study:
- To highlight the significance of mitochondrial metabolic phenotypes in cancer.
- To discuss the role of metabolic plasticity in metastasis and therapy resistance.
- To underscore the potential of targeting cancer metabolic dependencies for novel therapeutics.
Main Methods:
- Review of current literature on mitochondrial function in cancer.
- Analysis of metabolic phenotypes including glycolysis and OXPHOS.
- Examination of tumor microenvironment interactions with cancer cell mitochondria.
Main Results:
- Mitochondria adapt metabolic phenotypes to meet cancer's high energy demands.
- Cancer cells can adopt a hybrid metabolic phenotype, utilizing both glycolysis and OXPHOS.
- This metabolic plasticity contributes to cancer metastasis and resistance to therapy.
Conclusions:
- Mitochondrial metabolic heterogeneity and plasticity are critical in cancer.
- Targeting cancer's metabolic dependencies offers a promising therapeutic strategy.
- Exploiting mitochondrial roles could lead to novel and effective cancer treatments.
More Related Videos
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Emerging Adulthood
Introduction Cardiac Emergencies
Therapeutic Index
Applications of GIS: Disaster Management and Emergency Response
Therapeutic Communication
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...

